Granules India Limited Price (GRANULES.NS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

242,350,000

(1.3795)%

Granules Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $389.35-721
  • Market Cap 120.16B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

  • ceo: Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.
  • IPO Date: June, 20, 2005
  • Country: IN
  • Currency: INR
  • Headquaters: No Data
  • Employees: 4057

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation